Implanet received CE mark approval for its Jazz Cap System.
Spinal Tech
WishBone Medical acquired Response Ortho.
A former Insys Therapeutics executive pleaded guilty for his role in a conspiracy to defraud insurers by bribing physicians to unnecessarily prescribe a fentanyl-based drug, according to NBC News.
FloSpine is a spinal implant company.
The FDA will overhaul its 510(k) clearance pathway for medical devices.
Warsaw, Ind., is known as the 'orthopedic capital of the world,' according to Wane.com, featuring Zimmer Biomet, Medtronic and DePuy Synthes manufacturing locations.
Stryker priced four senior notes offerings, totaling $2.56 billion.
Here are nine key notes from orthopedic and spine device companies in the past week.
Auris Health received $220 million in equity financing to advance the commercialization of its endobronchial Monarch Platform and robotic technology development.
AmeriHealth Caritas now exclusively covers Paradigm Spine's coflex interlaminar stabilization device for lumbar spinal stenosis treatment.
